BackUnity Biotechnology Overview

Unity Biotechnology Total Assets

Unity Biotechnology's total assets is $30M.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$30.35M
↓ 48.44% YoYΔ $-28.52M vs prior year quarter

Peer trimmed avg / median

Loading

Unity Biotechnology Total Assets History

Loading

Unity Biotechnology vs. peers: Total Assets Comparison

Loading

Unity Biotechnology Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Unity Biotechnology (UBX) FAQ

The latest total assets for UBX is $30M as of March 2025. That compares with $59M in the prior-year period — down 48.4% year over year. Investors often review this figure alongside Unity Biotechnology's historical trend and sector peers before judging valuation or financial health.

Over the past year, UBX's total assets moved from $59M to $30M — a 48.4% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Unity Biotechnology's operating scale or balance-sheet position.

A total assets figure of $30M for UBX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting UBX's total assets ($30M), review year-over-year change from $59M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Unity Biotechnology's total assets against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.